chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 89.0
Sex: U
Vaccine: COVID19
Symptoms: Malaise
Clinical narrative: 89 year old was in bed for 2 days after receiving moderna vaccine; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (89 year old was in bed for 2 days after receiving moderna vaccine) in an 89-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Apr-2021, the patient experienced MALAISE (89 year old was in bed for 2 days after receiving moderna vaccine). At the time of the report, MALAISE (89 year old was in bed for 2 days after receiving moderna vaccine) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not reported.  Treatment information were not provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-068360, MOD21-070439, US-MODERNATX, INC.-MOD-2021-068645 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-068360: MOD21-070439: US-MODERNATX, INC.-MOD-2021-068645:
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Lymphadenopathy, Oropharyngeal pain, Peripheral swelling, Throat irritation
Clinical narrative: draining down my throat; it started to hurt a little bit; it's swollen and sore; glands are all swollen; chills; This spontaneous case was reported by a consumer and describes the occurrence of THROAT IRRITATION (draining down my throat), OROPHARYNGEAL PAIN (it started to hurt a little bit), PERIPHERAL SWELLING (it's swollen and sore), LYMPHADENOPATHY (glands are all swollen) and CHILLS (chills) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026B21A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 pneumonia.    On 05-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Apr-2021, the patient experienced THROAT IRRITATION (draining down my throat), OROPHARYNGEAL PAIN (it started to hurt a little bit), PERIPHERAL SWELLING (it's swollen and sore), LYMPHADENOPATHY (glands are all swollen) and CHILLS (chills). The patient was treated with CAFFEINE, PARACETAMOL (EXCEDRIN [CAFFEINE;PARACETAMOL]) ongoing since an unknown date for Pain relief, at a dose of 1 dosage form. At the time of the report, THROAT IRRITATION (draining down my throat), OROPHARYNGEAL PAIN (it started to hurt a little bit), PERIPHERAL SWELLING (it's swollen and sore), LYMPHADENOPATHY (glands are all swollen) and CHILLS (chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.        The patient had covid pneumonia in January and received the antibody treatment with that diagnosis.  No concomitant medication provided.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site rash, Vaccination site swelling
Clinical narrative: it's very itchy; redness at the injection site; swelling at the injection site; rash at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (rash at the injection site), VACCINATION SITE PRURITUS (it's very itchy), VACCINATION SITE ERYTHEMA (redness at the injection site) and VACCINATION SITE SWELLING (swelling at the injection site) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Mar-2021, the patient experienced VACCINATION SITE RASH (rash at the injection site). On 06-Apr-2021, the patient experienced VACCINATION SITE PRURITUS (it's very itchy), VACCINATION SITE ERYTHEMA (redness at the injection site) and VACCINATION SITE SWELLING (swelling at the injection site). At the time of the report, VACCINATION SITE RASH (rash at the injection site), VACCINATION SITE PRURITUS (it's very itchy), VACCINATION SITE ERYTHEMA (redness at the injection site) and VACCINATION SITE SWELLING (swelling at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided.   The patient received treatment with Benadryl cream.
Age: 16.0
Sex: M
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: patient who is 16 years old received the Moderna COVID 19 vaccine; This spontaneous case was reported by a health care professional and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (patient who is 16 years old received the Moderna COVID 19 vaccine) in a 16-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 02B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Apr-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (patient who is 16 years old received the Moderna COVID 19 vaccine). On 06-Apr-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (patient who is 16 years old received the Moderna COVID 19 vaccine) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.   Treatment information was not provided.
Sex: F
Vaccine: COVID19
Symptoms: Exposure to SARS-CoV-2
Clinical narrative: Patient was exposed to COVID after getting the first dose; This spontaneous case was reported by a consumer and describes the occurrence of EXPOSURE TO SARS-COV-2 (Patient was exposed to COVID after getting the first dose) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPOSURE TO SARS-COV-2 (Patient was exposed to COVID after getting the first dose). At the time of the report, EXPOSURE TO SARS-COV-2 (Patient was exposed to COVID after getting the first dose) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       no treatment  information were provided no concomitant medications were provided
Age: 21.0
Sex: F
Vaccine: COVID19
Symptoms: Wrong product administered
Clinical narrative: wrong second dose; This spontaneous case was reported by a nurse and describes the occurrence of WRONG PRODUCT ADMINISTERED (wrong second dose) in a 21-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced WRONG PRODUCT ADMINISTERED (wrong second dose). At the time of the report, WRONG PRODUCT ADMINISTERED (wrong second dose) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   Wrong second dose of Pfizer's vaccine was given  No treatment information were provided No concomitant medications information were provided
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Hypoaesthesia oral, Nausea, Pain in extremity, Vaccination site erythema
Clinical narrative: itchy at the injection site; red at the injection site; welt at the injection site; lightheaded; nauseous; upper lip became numb; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA ORAL (upper lip became numb), PAIN IN EXTREMITY (sore arm), DIZZINESS (lightheaded), NAUSEA (nauseous) and VACCINATION SITE PRURITUS (itchy at the injection site) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 036A21A and 019B29A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Blood pressure high since 06-Apr-2021.   On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 04-Mar-2021, the patient experienced HYPOAESTHESIA ORAL (upper lip became numb) and PAIN IN EXTREMITY (sore arm). On 06-Mar-2021, the patient experienced DIZZINESS (lightheaded) and NAUSEA (nauseous). On 07-Mar-2021, the patient experienced VACCINATION SITE PRURITUS (itchy at the injection site), VACCINATION SITE ERYTHEMA (red at the injection site) and VACCINATION SITE URTICARIA (welt at the injection site). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date for Fever, at a dose of UNK dosage form; DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN (ROBITUSSIN DM) ongoing since an unknown date for Cough, at a dose of UNK dosage form and MENTHOL (ICE [MENTHOL]) ongoing since an unknown date at a dose of UNK dosage form. On 06-Mar-2021, HYPOAESTHESIA ORAL (upper lip became numb) had resolved. On 08-Mar-2021, DIZZINESS (lightheaded) and NAUSEA (nauseous) had resolved. On 09-Mar-2021, PAIN IN EXTREMITY (sore arm) had resolved. On 10-Mar-2021, VACCINATION SITE PRURITUS (itchy at the injection site), VACCINATION SITE ERYTHEMA (red at the injection site) and VACCINATION SITE URTICARIA (welt at the injection site) had resolved.            No concomitant information were provided
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pruritus, Vaccination site urticaria
Clinical narrative: itchy at the injection site; red at the injection site; welt at the injection site; lightheaded; nauseous; upper lip became numb; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA ORAL (upper lip became numb), PAIN IN EXTREMITY (sore arm), DIZZINESS (lightheaded), NAUSEA (nauseous) and VACCINATION SITE PRURITUS (itchy at the injection site) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 036A21A and 019B29A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Blood pressure high since 06-Apr-2021.   On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 04-Mar-2021, the patient experienced HYPOAESTHESIA ORAL (upper lip became numb) and PAIN IN EXTREMITY (sore arm). On 06-Mar-2021, the patient experienced DIZZINESS (lightheaded) and NAUSEA (nauseous). On 07-Mar-2021, the patient experienced VACCINATION SITE PRURITUS (itchy at the injection site), VACCINATION SITE ERYTHEMA (red at the injection site) and VACCINATION SITE URTICARIA (welt at the injection site). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date for Fever, at a dose of UNK dosage form; DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN (ROBITUSSIN DM) ongoing since an unknown date for Cough, at a dose of UNK dosage form and MENTHOL (ICE [MENTHOL]) ongoing since an unknown date at a dose of UNK dosage form. On 06-Mar-2021, HYPOAESTHESIA ORAL (upper lip became numb) had resolved. On 08-Mar-2021, DIZZINESS (lightheaded) and NAUSEA (nauseous) had resolved. On 09-Mar-2021, PAIN IN EXTREMITY (sore arm) had resolved. On 10-Mar-2021, VACCINATION SITE PRURITUS (itchy at the injection site), VACCINATION SITE ERYTHEMA (red at the injection site) and VACCINATION SITE URTICARIA (welt at the injection site) had resolved.            No concomitant information were provided
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Chills, Cough, Oropharyngeal pain, Tremor
Clinical narrative: sore throat; coughing; body shakes; stomach hurts; chills; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (sore throat), COUGH (coughing), TREMOR (body shakes), ABDOMINAL PAIN UPPER (stomach hurts) and CHILLS (chills) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On 27-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose.   On 27-Mar-2021, the patient experienced OROPHARYNGEAL PAIN (sore throat), COUGH (coughing), TREMOR (body shakes), ABDOMINAL PAIN UPPER (stomach hurts) and CHILLS (chills). At the time of the report, OROPHARYNGEAL PAIN (sore throat), COUGH (coughing), TREMOR (body shakes), ABDOMINAL PAIN UPPER (stomach hurts) and CHILLS (chills) outcome was unknown. Not Provided    The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   Concomitant medications was reported as the patient took blood pressure and thyroid hormones medications.  No laboratory details was mentioned. Treatment information was provided as the patient took benadryl   Most recent FOLLOW-UP information incorporated above includes: On 18-May-2021: TCR addded
Sex: F
Vaccine: COVID19
Symptoms: Rhinitis allergic, Upper-airway cough syndrome
Clinical narrative: chronic post nasal drip; it was like allergies except she is not sneezing or congested.; This spontaneous case was reported by a consumer and describes the occurrence of UPPER-AIRWAY COUGH SYNDROME (chronic post nasal drip) and RHINITIS ALLERGIC (it was like allergies except she is not sneezing or congested.) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011L20A and 012M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 26-Jan-2021, the patient experienced UPPER-AIRWAY COUGH SYNDROME (chronic post nasal drip) and RHINITIS ALLERGIC (it was like allergies except she is not sneezing or congested.). At the time of the report, UPPER-AIRWAY COUGH SYNDROME (chronic post nasal drip) and RHINITIS ALLERGIC (it was like allergies except she is not sneezing or congested.) had not resolved. Not Provided      mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       Treatment included Flonase. Concomitant medications were not provided. Patient states she just has a constant drip.   This case was linked to.-MOD-2021-068420 (E2B Linked Report).; Sender's Comments:  MOD-2021-068420:dose 2
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Feeling cold, Headache, Illness, Migraine
Clinical narrative: Severe migraine; Very ill; Dizzy in her eye; Nauseous; Freeze in the night/Cold; Slight headache; This spontaneous case was reported by a consumer and describes the occurrence of FEELING COLD (Freeze in the night/Cold), MIGRAINE (Severe migraine), ILLNESS (Very ill), DIZZINESS (Dizzy in her eye) and HEADACHE (Slight headache) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Mar-2021, the patient experienced FEELING COLD (Freeze in the night/Cold) and HEADACHE (Slight headache). On 01-Apr-2021, the patient experienced NAUSEA (Nauseous). On 04-Apr-2021, the patient experienced ILLNESS (Very ill) and DIZZINESS (Dizzy in her eye). On 05-Apr-2021, the patient experienced MIGRAINE (Severe migraine). The patient was treated with IBUPROFEN ongoing since an unknown date at a dose of UNK dosage form. On 01-Apr-2021, FEELING COLD (Freeze in the night/Cold) had resolved. On 04-Apr-2021, ILLNESS (Very ill) and DIZZINESS (Dizzy in her eye) was resolving. On 05-Apr-2021, MIGRAINE (Severe migraine) had resolved. At the time of the report, HEADACHE (Slight headache) and NAUSEA (Nauseous) was resolving. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication was not reported. Treatment medication reported was ibuprofen.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea
Clinical narrative: Severe migraine; Very ill; Dizzy in her eye; Nauseous; Freeze in the night/Cold; Slight headache; This spontaneous case was reported by a consumer and describes the occurrence of FEELING COLD (Freeze in the night/Cold), MIGRAINE (Severe migraine), ILLNESS (Very ill), DIZZINESS (Dizzy in her eye) and HEADACHE (Slight headache) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Mar-2021, the patient experienced FEELING COLD (Freeze in the night/Cold) and HEADACHE (Slight headache). On 01-Apr-2021, the patient experienced NAUSEA (Nauseous). On 04-Apr-2021, the patient experienced ILLNESS (Very ill) and DIZZINESS (Dizzy in her eye). On 05-Apr-2021, the patient experienced MIGRAINE (Severe migraine). The patient was treated with IBUPROFEN ongoing since an unknown date at a dose of UNK dosage form. On 01-Apr-2021, FEELING COLD (Freeze in the night/Cold) had resolved. On 04-Apr-2021, ILLNESS (Very ill) and DIZZINESS (Dizzy in her eye) was resolving. On 05-Apr-2021, MIGRAINE (Severe migraine) had resolved. At the time of the report, HEADACHE (Slight headache) and NAUSEA (Nauseous) was resolving. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication was not reported. Treatment medication reported was ibuprofen.
Age: 22.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Heart rate increased, Hyperhidrosis, Hypoaesthesia, Hypotension
Clinical narrative: Nausea; Hypotension; Visual Impairment; Chills; aches; Fever; Right foot swelling; limbs numb; feeling of rapid heart rate; sweating; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills), PAIN (aches), PYREXIA (Fever), PERIPHERAL SWELLING (Right foot swelling) and HYPOAESTHESIA (limbs numb) in a 22-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 19B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Blood pressure low.    On 05-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Apr-2021, the patient experienced CHILLS (Chills), PAIN (aches), PYREXIA (Fever), PERIPHERAL SWELLING (Right foot swelling), HYPOAESTHESIA (limbs numb), HEART RATE INCREASED (feeling of rapid heart rate) and HYPERHIDROSIS (sweating). On an unknown date, the patient experienced NAUSEA (Nausea), HYPOTENSION (Hypotension) and VISUAL IMPAIRMENT (Visual Impairment). At the time of the report, CHILLS (Chills), PAIN (aches), PYREXIA (Fever), PERIPHERAL SWELLING (Right foot swelling), HYPOAESTHESIA (limbs numb), HEART RATE INCREASED (feeling of rapid heart rate), HYPERHIDROSIS (sweating), NAUSEA (Nausea), HYPOTENSION (Hypotension) and VISUAL IMPAIRMENT (Visual Impairment) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications include Allergy medication, Anxiety, Adderall No treatment information were provided
Age: 22.0
Sex: M
Vaccine: COVID19
Symptoms: Nausea, Pain, Peripheral swelling, Pyrexia, Visual impairment
Clinical narrative: Nausea; Hypotension; Visual Impairment; Chills; aches; Fever; Right foot swelling; limbs numb; feeling of rapid heart rate; sweating; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills), PAIN (aches), PYREXIA (Fever), PERIPHERAL SWELLING (Right foot swelling) and HYPOAESTHESIA (limbs numb) in a 22-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 19B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Blood pressure low.    On 05-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Apr-2021, the patient experienced CHILLS (Chills), PAIN (aches), PYREXIA (Fever), PERIPHERAL SWELLING (Right foot swelling), HYPOAESTHESIA (limbs numb), HEART RATE INCREASED (feeling of rapid heart rate) and HYPERHIDROSIS (sweating). On an unknown date, the patient experienced NAUSEA (Nausea), HYPOTENSION (Hypotension) and VISUAL IMPAIRMENT (Visual Impairment). At the time of the report, CHILLS (Chills), PAIN (aches), PYREXIA (Fever), PERIPHERAL SWELLING (Right foot swelling), HYPOAESTHESIA (limbs numb), HEART RATE INCREASED (feeling of rapid heart rate), HYPERHIDROSIS (sweating), NAUSEA (Nausea), HYPOTENSION (Hypotension) and VISUAL IMPAIRMENT (Visual Impairment) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications include Allergy medication, Anxiety, Adderall No treatment information were provided
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Feeling hot, Headache, Nausea, Pain
Clinical narrative: Dizzy; Felt like they were overheating; Rash on left arm; Felt achy; Wanted to sleep; Nausea (dry heaving),couldn't eat because of it; Overnight woke up with pounding headaches; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizzy), PAIN (Felt achy), SOMNOLENCE (Wanted to sleep), FEELING HOT (Felt like they were overheating) and RASH (Rash on left arm) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 017B21A and 024M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included ESTRADIOL for an unknown indication.   On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 25-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced HEADACHE (Overnight woke up with pounding headaches). On 26-Mar-2021, the patient experienced PAIN (Felt achy), SOMNOLENCE (Wanted to sleep) and NAUSEA (Nausea (dry heaving),couldn't eat because of it). On 28-Mar-2021, the patient experienced DIZZINESS (Dizzy), FEELING HOT (Felt like they were overheating) and RASH (Rash on left arm). On 30-Mar-2021, DIZZINESS (Dizzy), PAIN (Felt achy), SOMNOLENCE (Wanted to sleep), FEELING HOT (Felt like they were overheating), RASH (Rash on left arm), HEADACHE (Overnight woke up with pounding headaches) and NAUSEA (Nausea (dry heaving),couldn't eat because of it) had resolved.            Action taken with mRNA-1273 in response to the event was not applicable.  Treatment medication included Tylenol and lotion.   This case was linked to MOD-2021-068389 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 17-May-2021: Patient's demographics was updated.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, Somnolence
Clinical narrative: Dizzy; Felt like they were overheating; Rash on left arm; Felt achy; Wanted to sleep; Nausea (dry heaving),couldn't eat because of it; Overnight woke up with pounding headaches; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizzy), PAIN (Felt achy), SOMNOLENCE (Wanted to sleep), FEELING HOT (Felt like they were overheating) and RASH (Rash on left arm) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 017B21A and 024M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included ESTRADIOL for an unknown indication.   On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 25-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced HEADACHE (Overnight woke up with pounding headaches). On 26-Mar-2021, the patient experienced PAIN (Felt achy), SOMNOLENCE (Wanted to sleep) and NAUSEA (Nausea (dry heaving),couldn't eat because of it). On 28-Mar-2021, the patient experienced DIZZINESS (Dizzy), FEELING HOT (Felt like they were overheating) and RASH (Rash on left arm). On 30-Mar-2021, DIZZINESS (Dizzy), PAIN (Felt achy), SOMNOLENCE (Wanted to sleep), FEELING HOT (Felt like they were overheating), RASH (Rash on left arm), HEADACHE (Overnight woke up with pounding headaches) and NAUSEA (Nausea (dry heaving),couldn't eat because of it) had resolved.            Action taken with mRNA-1273 in response to the event was not applicable.  Treatment medication included Tylenol and lotion.   This case was linked to MOD-2021-068389 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 17-May-2021: Patient's demographics was updated.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Pyrexia
Clinical narrative: Fever of 100 degrees; Not feeling too good; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever of 100 degrees) and FEELING ABNORMAL (Not feeling too good) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included ESOMEPRAZOLE MAGNESIUM (NEXIUM 24HR) for an unknown indication.   On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 25-Feb-2021, the patient experienced PYREXIA (Fever of 100 degrees) and FEELING ABNORMAL (Not feeling too good). On 26-Feb-2021, PYREXIA (Fever of 100 degrees) had resolved. On 28-Feb-2021, FEELING ABNORMAL (Not feeling too good) had resolved. Unknown    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 25-Feb-2021, Pyrexia: 100 degree.         Treatment information was not provided  Action taken with mRNA-1273 in response to the events was not Applicable.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Cold sweat, Headache, Pyrexia
Clinical narrative: cold sweats; fever; headache; This spontaneous case was reported by a consumer and describes the occurrence of COLD SWEAT (cold sweats), PYREXIA (fever) and HEADACHE (headache) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).   On 11-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Apr-2021, the patient experienced COLD SWEAT (cold sweats), PYREXIA (fever) and HEADACHE (headache). The patient was treated with NAPROXEN SODIUM (ALEVE) at an unspecified dose and frequency. At the time of the report, COLD SWEAT (cold sweats), PYREXIA (fever) and HEADACHE (headache) outcome was unknown.            The action taken with mRNA-1273 in response to the event was not applicable. Concomitant medication information not provided.
Age: 21.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure measurement, Chest X-ray, Electrocardiogram, Heart rate, Influenza like illness
Clinical narrative: Flu-like symptoms; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu-like symptoms) in a 21-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 017B21A and 032M20A) for COVID-19 vaccination.     The patient's past medical history included Epilepsy (Childhood epilepsy) and Migraine since an unknown date. Concurrent medical conditions included Peanut allergy (patient has had an anaphylactic reaction to peanuts in the past.). Concomitant products included AMITRIPTYLINE for an unknown indication.   On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-Mar-2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu-like symptoms). On 07-Mar-2021, INFLUENZA LIKE ILLNESS (Flu-like symptoms) had resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 03-Apr-2021, Blood pressure measurement: 130/70 mmHg diastolic reading was approximate. On 03-Apr-2021, Chest X-ray: Inconclusive. On 03-Apr-2021, Electrocardiogram: Inconclusive. On 03-Apr-2021, Heart rate: 133 133 bpm. On 03-Apr-2021, Laboratory test: Inconclusive.         Diagnostic tests are done for the  event happened after second Moderna vaccine dose.   Concomitant product include Birth control pills. No treatment information was reported.   This case was linked to US-MODERNATX, INC.-MOD-2021-068419 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-068419:LINKED WITH DOSE 2
Age: 21.0
Sex: F
Vaccine: COVID19
Symptoms: Laboratory test
Clinical narrative: Flu-like symptoms; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu-like symptoms) in a 21-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 017B21A and 032M20A) for COVID-19 vaccination.     The patient's past medical history included Epilepsy (Childhood epilepsy) and Migraine since an unknown date. Concurrent medical conditions included Peanut allergy (patient has had an anaphylactic reaction to peanuts in the past.). Concomitant products included AMITRIPTYLINE for an unknown indication.   On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-Mar-2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu-like symptoms). On 07-Mar-2021, INFLUENZA LIKE ILLNESS (Flu-like symptoms) had resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 03-Apr-2021, Blood pressure measurement: 130/70 mmHg diastolic reading was approximate. On 03-Apr-2021, Chest X-ray: Inconclusive. On 03-Apr-2021, Electrocardiogram: Inconclusive. On 03-Apr-2021, Heart rate: 133 133 bpm. On 03-Apr-2021, Laboratory test: Inconclusive.         Diagnostic tests are done for the  event happened after second Moderna vaccine dose.   Concomitant product include Birth control pills. No treatment information was reported.   This case was linked to US-MODERNATX, INC.-MOD-2021-068419 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-068419:LINKED WITH DOSE 2
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 antibody test
Clinical narrative: Patient tested positive for COVID-19 after first vaccine dose; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of COVID-19 (Patient tested positive for COVID-19 after first vaccine dose) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (Patient tested positive for COVID-19 after first vaccine dose). At the time of the report, COVID-19 (Patient tested positive for COVID-19 after first vaccine dose) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 antibody test: negative (Negative) Anti-body test was done and it was negative, and doctor told the patient to start over the vaccine process..     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication list was not provided. Treatment provided include IV medicine for COVID-19.
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Menstruation delayed
Clinical narrative: period is a week late; This spontaneous case was reported by a consumer and describes the occurrence of MENSTRUATION DELAYED (period is a week late) in a 22-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination.     Concurrent medical conditions included ADD. Concomitant products included LISDEXAMFETAMINE MESILATE (VYVANSE) for ADD.    On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MENSTRUATION DELAYED (period is a week late). At the time of the report, MENSTRUATION DELAYED (period is a week late) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided.  Reportedly, when the agent asked if she could be pregnant, the patient said that she don't think it could be pregnant.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Intentional product use issue
Clinical narrative: more than 36 days after the first dose without receiving second dose; This spontaneous case was reported by a consumer and describes the occurrence of INTENTIONAL PRODUCT USE ISSUE (more than 36 days after the first dose without receiving second dose) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination.     The patient's past medical history included Breast cancer (history of breast cancer that affected left arm). Concurrent medical conditions included Back pain.    On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INTENTIONAL PRODUCT USE ISSUE (more than 36 days after the first dose without receiving second dose). At the time of the report, INTENTIONAL PRODUCT USE ISSUE (more than 36 days after the first dose without receiving second dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant Medication was available. No Treatment Medication was available. Patient stated that the 2nd dose was scheduled on 12Mar2021 but had a back pain management surgery that was scheduled on the same day where she was receiving injection shots
Age: 41.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Pyrexia
Clinical narrative: A temperature 101 F all day; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (A temperature 101 F all day) in a 41-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history provided.).   On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 06-Apr-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PYREXIA (A temperature 101 F all day). At the time of the report, PYREXIA (A temperature 101 F all day) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 06-Apr-2021, Body temperature: 101 Increased body temperature and 102.8 Increased body temperature.         Concomitant product use was not provided.  Treatment information included Tylenol.  Action taken with mRNA-1273 in response to events was not applicable.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Age: 67.0
Sex: U
Vaccine: COVID19
Symptoms: Fatigue, Headache, Pain in extremity
Clinical narrative: Upper arm pain; Headache; Intense fatigue; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Upper arm pain), HEADACHE (Headache) and FATIGUE (Intense fatigue) in a 67-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination.     Concurrent medical conditions included Vaccination adverse reaction (Patient always had problems with vaccines ).    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On 01-Mar-2021, the patient experienced PAIN IN EXTREMITY (Upper arm pain), HEADACHE (Headache) and FATIGUE (Intense fatigue). On 04-Mar-2021, HEADACHE (Headache) had resolved. On 05-Mar-2021, FATIGUE (Intense fatigue) had resolved. In March 2021, PAIN IN EXTREMITY (Upper arm pain) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       No concomitant medications provided. On 01-Mar-2021, the patient Tylenol as treatment for her headache.   This case was linked to MOD-2021-068421 (Patient Link).
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Myalgia, Nausea, Pain
Clinical narrative: rash at the injection site, and it is itchy; chills; aches; a lump on the arm of the injection ( Left arm); muscle aches; joint pain; nausea; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills), PAIN (aches), VACCINATION SITE MASS (a lump on the arm of the injection ( Left arm)), MYALGIA (muscle aches) and ARTHRALGIA (joint pain) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 021B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Hypertension (No reported medical history) and Hyperlipidemia.   On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 02-Apr-2021, the patient experienced CHILLS (chills), PAIN (aches), VACCINATION SITE MASS (a lump on the arm of the injection ( Left arm)), MYALGIA (muscle aches), ARTHRALGIA (joint pain) and NAUSEA (nausea). On 06-Apr-2021, the patient experienced RASH PRURITIC (rash at the injection site, and it is itchy). The patient was treated with PARACETAMOL (TYLENOL) on 02-Apr-2021 at an unspecified dose and frequency and CORTISONE ACETATE (CORTISOL [CORTISONE ACETATE]) on 06-Apr-2021 at a dose of UNK,Cortisol cream at the injection site. At the time of the report, CHILLS (chills), PAIN (aches), VACCINATION SITE MASS (a lump on the arm of the injection ( Left arm)), MYALGIA (muscle aches), ARTHRALGIA (joint pain) and NAUSEA (nausea) had resolved and RASH PRURITIC (rash at the injection site, and it is itchy) outcome was unknown.            The action taken with mRNA-1273 in response to the event was not applicable. Concomitant medications included blood pressure and cholesterol medication.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Rash pruritic, Vaccination site mass
Clinical narrative: rash at the injection site, and it is itchy; chills; aches; a lump on the arm of the injection ( Left arm); muscle aches; joint pain; nausea; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills), PAIN (aches), VACCINATION SITE MASS (a lump on the arm of the injection ( Left arm)), MYALGIA (muscle aches) and ARTHRALGIA (joint pain) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 021B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Hypertension (No reported medical history) and Hyperlipidemia.   On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 02-Apr-2021, the patient experienced CHILLS (chills), PAIN (aches), VACCINATION SITE MASS (a lump on the arm of the injection ( Left arm)), MYALGIA (muscle aches), ARTHRALGIA (joint pain) and NAUSEA (nausea). On 06-Apr-2021, the patient experienced RASH PRURITIC (rash at the injection site, and it is itchy). The patient was treated with PARACETAMOL (TYLENOL) on 02-Apr-2021 at an unspecified dose and frequency and CORTISONE ACETATE (CORTISOL [CORTISONE ACETATE]) on 06-Apr-2021 at a dose of UNK,Cortisol cream at the injection site. At the time of the report, CHILLS (chills), PAIN (aches), VACCINATION SITE MASS (a lump on the arm of the injection ( Left arm)), MYALGIA (muscle aches), ARTHRALGIA (joint pain) and NAUSEA (nausea) had resolved and RASH PRURITIC (rash at the injection site, and it is itchy) outcome was unknown.            The action taken with mRNA-1273 in response to the event was not applicable. Concomitant medications included blood pressure and cholesterol medication.
Sex: M
Vaccine: COVID19
Symptoms: Chills, Constipation, Feeling abnormal, Nausea, Pyrexia
Clinical narrative: almost killed me; threw up; fever 102.7/Fever (102.5F); constipation; chills; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever 102.7/Fever (102.5F)), CONSTIPATION (constipation), CHILLS (chills), NAUSEA (Nausea) and FEELING ABNORMAL (almost killed me) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No reported medical history).    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced PYREXIA (fever 102.7/Fever (102.5F)), CONSTIPATION (constipation), CHILLS (chills) and NAUSEA (Nausea). On an unknown date, the patient experienced FEELING ABNORMAL (almost killed me) and VOMITING (threw up). At the time of the report, PYREXIA (fever 102.7/Fever (102.5F)), CONSTIPATION (constipation), CHILLS (chills), NAUSEA (Nausea), FEELING ABNORMAL (almost killed me) and VOMITING (threw up) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 06-Apr-2021: address, email, outcome of events updated
Sex: M
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: almost killed me; threw up; fever 102.7/Fever (102.5F); constipation; chills; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever 102.7/Fever (102.5F)), CONSTIPATION (constipation), CHILLS (chills), NAUSEA (Nausea) and FEELING ABNORMAL (almost killed me) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No reported medical history).    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced PYREXIA (fever 102.7/Fever (102.5F)), CONSTIPATION (constipation), CHILLS (chills) and NAUSEA (Nausea). On an unknown date, the patient experienced FEELING ABNORMAL (almost killed me) and VOMITING (threw up). At the time of the report, PYREXIA (fever 102.7/Fever (102.5F)), CONSTIPATION (constipation), CHILLS (chills), NAUSEA (Nausea), FEELING ABNORMAL (almost killed me) and VOMITING (threw up) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 06-Apr-2021: address, email, outcome of events updated